Fintel reports that on March 25, 2025, Evercore ISI Group initiated coverage of OneMain Holdings (NYSE:OMF) with a In-Line ...

Evercore ISI downgraded Lennar (LEN) to In Line from Outperform after a call with management indicated that the homebuilder ...

In a report released yesterday, Michael Binetti from Evercore ISI maintained a Buy rating on Lululemon Athletica (LULU – Research Report), with ...

In a report released on March 21, Umer Raffat from Evercore ISI maintained a Buy rating on Apellis Pharmaceuticals (APLS – Research Report).

Equities researchers at Evercore ISI started coverage on shares of Repligen (NASDAQ:RGEN – Get Free Report) in a report ...

Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform ...

On Wednesday, Evercore ISI upgraded Capital One Financial shares, listed on the NYSE under the ticker COF, from In Line to Outperform, setting a price target of $200.00. Trading at $165.40 with a ...

On Wednesday, Evercore ISI began coverage on Summit Therapeutics plc (NASDAQ:SMMT) shares, assigning an Outperform rating and setting a price target of $30.00. The $13.65 billion market cap ...

Evercore ISI upgraded Capital One Financial to Outperform from In Line, bolstered by the conviction that the bank's "idiosyncratic factors provide upside earnings optionality in the face of ...

Carvana (NYSE:CVNA – Free Report) had its price target lowered by Evercore ISI from $250.00 to $240.00 in a report issued on Tuesday,Benzinga reports. Evercore ISI currently has an in-line ...

On Wednesday, Evercore ISI began coverage on Summit Therapeutics plc (NASDAQ:SMMT) shares, assigning an Outperform rating and setting a price target of $30.00. The $13.65 billion market cap company, ...

Investing.com -- Evercore ISI upgraded Capital One Financial Corp (NYSE:COF) to "Outperform" from "In Line," focusing on long-term earnings upside from its pending acquisition of Discover ...